Company Overview of Innovir Laboratories Inc., Prior to the reverse acquisition with VIMRx Pharmaceuticals Inc.
In December 1996, Innovir Laboratories, Inc. and VIMRx Pharmaceuticals, Inc. (VIMRx) consummated a transaction, whereby VIMRx acquired 68% of the outstanding stock of Innovir and Innovir acquired all of the issued and outstanding shares of VIMRx Holdings, Ltd. (VHL), a wholly owned subsidiary of VIMRx. The transaction resulted in a reverse acquisition, whereby VHL acquired Innovir. Prior to the acquisition, Innovir Laboratories, Inc., a biotechnology company, was engaged in developing a new class of therapeutic agents based on proprietary technology.
510 East 73rd Street
New York, NY 10021
Founded in 1989
Key Executives for Innovir Laboratories Inc., Prior to the reverse acquisition with VIMRx Pharmaceuticals Inc.
Innovir Laboratories Inc., Prior to the reverse acquisition with VIMRx Pharmaceuticals Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Innovir Laboratories Inc., Prior to the reverse acquisition with VIMRx Pharmaceuticals Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.